Professor, Internal Medicine, Wayne State University School of Medicine
Infectious Disease
Dr. Louis D. Saravolatz, MD
|
|
Give Review
Louis Saravolatz practices Infectious Disease. He researched medicine at University of Michigan Medical School. He received 1 awards: "Super Doctor". Louis Saravolatz is a published doctor. He published 101 publications, including: 'CD4+ T lymphocyte counts and patterns of mortality among patients infected with human immunodeficiency virus who were enrolled in community programs for clinical resea...' He is registered with Medicare.
Publications
- Current Strategies in the Evaluation and Management of Cocaine-Induced Chest Pain.
- Dilemmas in end-stage heart failure.
- Novel Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation.
- Diabetic hearts have lower basal urocortin levels that fail to increase after cardioplegic arrest: Association with increased apoptosis and postsurgical cardiac dysfun...
- Improving Foot Examinations in Patients With Diabetes: A Performance Improvement Continuing Medical Education (PI-CME) Project.
- Ceftaroline Heteroresistant Staphylococcus aureus.
- The Quad Pill, a Once-Daily Combination Therapy for HIV Infection.
- CHA2DS 2-VASc versus CHADS2 for stroke risk assessment in low-risk patients with atrial fibrillation: a pilot study from a single center of the NCDR-PINNACLE registry.
- The cardioprotective effects of urocortin are mediated via activation of the Src tyrosine kinase-STAT3 pathway.
- Peripheral venous catheter care in the emergency department: education and feedback lead to marked improvements.
- Rilpivirine: a new non-nucleoside reverse transcriptase inhibitor.
- Sustained reductions in urinary catheter use over 5 years: Bedside nurses view themselves responsible for evaluation of catheter necessity.
- In Vitro Susceptibilities and Molecular Analysis of Vancomycin-Intermediate and Vancomycin-Resistant Staphylococcus aureus Isolates.
- In Vitro Activities of LTX-109, a Synthetic Antimicrobial Peptide, against Methicillin-Resistant, Vancomycin-Intermediate, Vancomycin-Resistant, Daptomycin-Nonsuscepti...
- Sustained improvements in peripheral venous catheter care in non-intensive care units: a quasi-experimental controlled study of education and feedback.
- Routine HIV Testing in Primary Care Clinics: A Study Evaluating Patient and Provider Acceptance.
- Comparison of BACTEC™ plus Aerobic/F and VersaTREK REDOX(®) blood culture media for the recovery of Staphylococcus aureus from patients with suspected persistent bacte...
- Ceftaroline: a novel cephalosporin with activity against methicillin-resistant Staphylococcus aureus.
- Rapid diagnosis of septic arthritis using 16S rDNA PCR: a comparison of 3 methods.
- Urinary catheters in the emergency department: very elderly women are at high risk for unnecessary utilization.
- Effect of establishing guidelines on appropriate urinary catheter placement.
- Telavancin: a novel lipoglycopeptide.
- Etravirine, a next-generation nonnucleoside reverse-transcriptase inhibitor.
- Prevalence of colonization with community-associated methicillin-resistant Staphylococcus aureus among end-stage renal disease patients and healthcare workers.
- Effect of nurse-led multidisciplinary rounds on reducing the unnecessary use of urinary catheterization in hospitalized patients.
- Thrombin receptor and ventricular arrhythmias after acute myocardial infarction.
- Monotherapy versus combination therapy.
- Emergence of community-associated methicillin-resistant Staphylococcus aureus infection among patients with end-stage renal disease.
- A Web-based course on infection control for physicians in training: an educational intervention.
- Community-associated methicillin-resistant Staphylococcus aureus causing chronic pneumonia.
- Clinical and laboratory features of community-associated methicillin-resistant Staphylococcus aureus: is it really new?
- Nitazoxanide: a new thiazolide antiparasitic agent.
- Gatifloxacin, gemifloxacin, and moxifloxacin: the role of 3 newer fluoroquinolones.
- Do resident physicians use antibiotics appropriately in treating upper respiratory infections? A survey of 11 programs.
- Changing epidemiology of community-onset methicillin-resistant Staphylococcus aureus bacteremia.
- Parvovirus B19 infection presenting with necrotizing lymphadenitis.
- A randomized controlled trial evaluating the efficacy and safety of intermittent 3-, 4-, and 5-day cycles of intravenous recombinant human interleukin-2 combined with ...
- Broad-range bacterial polymerase chain reaction for early detection of bacterial meningitis.
- Comparison of five commercial western blot kits for detection of human immunodeficiency virus 1.
- Prevalence of antibody to the Legionnaires'' disease bacterium in hospital employees.
- Patterns of HIV-1 and HTLV-I/II in intravenous drug abusers from the middle atlantic and central regions of the USA.
- Prevalence of serum antibody to human immunodeficiency virus among hospitalized intravenous drug abusers in a low-risk geographic area.
- Imipenem-cilastatin in the treatment of methicillin-sensitive and methicillin-resistant Staphylococcus aureus infections.
- Comparison of ciprofloxacin and rifampicin in experimental Legionella pneumophila pneumonia.
- Effect of quinolones and other antimicrobial agents on cell-associated Legionella pneumophila.
- Antimicrobial treatment. A coordination challenge for nursing.
- Evaluation of the sterility and stability of insulin from multidose vials used for prolonged periods.
- Hemophilus influenzae pneumonia in the adult. Radiographic appearance with clinical correlation.
- Pneumonia due to Staphylococcus aureus infection.
- CD4+ T lymphocyte counts and patterns of mortality among patients infected with human immunodeficiency virus who were enrolled in community programs for clinical resea...
- Recurrent Klebsiella meningitis following trans-sphenoidal hypophysectomy for Nelson's syndrome. Chloramphenicol resistance during relapse.
- Antimicrobial activity of BMS 284756, a novel des-fluoro (6) quinolone and seven fluoroquinolones against Streptococcus pneumoniae.
- Antimicrobial activity of moxifloxacin, gatifloxacin and six fluoroquinolones against Streptococcus pneumoniae.
- Use of octreotide, a long-acting somatostatin analogue, in the treatment of chylothorax of idiopathic etiology.
- In-vitro activity of 29 antimicrobial agents against penicillin-resistant and -intermediate isolates of Streptococcus pneumoniae.
- Warm blood cardioplegic arrest induces mitochondrial-mediated cardiomyocyte apoptosis associated with increased urocortin expression in viable cells.
- Nutritional supplementation with mixed essential amino acids enhances myocyte survival, preserving mitochondrial functional capacity during ischemia-reperfusion injury.
- Differentiating inhalational anthrax from other influenza-like illnesses in the setting of a national or regional anthrax outbreak.
- Minocycline inhibits caspase activation and reactivation, increases the ratio of XIAP to smac/DIABLO, and reduces the mitochondrial leakage of cytochrome C and smac/DI...
- A case of fatal ephedra intake associated with lipofuscin accumulation, caspase activation and cleavage of myofibrillary proteins.
- Antimicrobial activity and a comparison of published pharmacodynamics of gemifloxacin and eight fluoroquinolones against Streptococcus pneumoniae.
- Increase in the rate of sternal surgical site infection after coronary artery bypass graft: a marker of higher severity of illness.
- Peripartum cardiomyopathy: a comprehensive review.
- Amino acid supplementation differentially modulates STAT1 and STAT3 activation in the myocardium exposed to ischemia/reperfusion injury.
- Oral administration of amino acidic supplements improves protein and energy profiles in skeletal muscle of aged rats: elongation of functional performance and accelera...
- Cardiac release of urocortin precedes the occurrence of irreversible myocardial damage in the rat heart exposed to ischemia/reperfusion injury.
- Warm-blood cardioplegic arrest induces selective mitochondrial translocation of protein kinase Cepsilon followed by interaction with 6.1 inwardly rectifying potassium ...
- Mechanisms of action and clinical implications of cardiac urocortin: a journey from the heart to the systemic circulation, with a stopover in the mitochondria.
- Harvest surgical site infection following coronary artery bypass grafting: risk factors, microbiology, and outcomes.
- Targeting STAT1 by myricetin and delphinidin provides efficient protection of the heart from ischemia/reperfusion-induced injury.
- Human immunodeficiency virus infection and autoimmune hepatitis during highly active anti-retroviral treatment: a case report and review of the literature.
- The role of minocycline in ischemia-reperfusion injury: a comprehensive review of an old drug with new implications.
- Activation of Src protein tyrosine kinase plays an essential role in urocortin-mediated cardioprotection.
- In vitro activity of oritavancin against community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA), vancomycin-intermediate S. aureus (VISA), vancomyc...
- Comparative activity of telavancin against isolates of community-associated methicillin-resistant Staphylococcus aureus.
- Persistently positive culture results in a patient with community-acquired pneumonia due to Legionella pneumophila.
- Pooled analysis of 3 randomized, controlled trials of interleukin-2 therapy in adult human immunodeficiency virus type 1 disease.
- Direct immunofluorescence in the diagnosis of Legionnaires' disease.
- Effect of clavulanic acid on minimal inhibitory concentrations of 16 antimicrobial agents tested against Legionella pneumophila.
- Cephapirin therapy in infective endocarditis.
- The risk of hepatitis B among select employee groups in an urban hospital.
- Comparison of HIV type 1 RNA plasma viremia, p24 antigenemia, and unintegrated DNA as viral load markers in pediatric patients.
- Gender is not a factor in serum human immunodeficiency virus type 1 RNA levels in patients with viremia.
- Zidovudine alone or in combination with didanosine or zalcitabine in HIV-infected patients with the acquired immunodeficiency syndrome or fewer than 200 CD4 cells per ...
- A study of HIV RNA viral load in AIDS patients with bacterial pneumonia.
- Changes in virus load markers during AIDS-associated opportunistic diseases in human immunodeficiency virus-infected persons.
- Selective inhibitory effects of stress hormones on natural killer (NK) cell activity of lymphocytes from AIDS patients.
- Frequencies of opportunistic diseases prior to death among HIV-infected persons. Community Programs for Clinical Research on AIDS.
- Pharmacokinetics of an IgM human monoclonal antibody against Pseudomonas aeruginosa in nonseptic patients.
- Increased detection of human immunodeficiency virus antigenemia after dissociation of immune complexes at low pH.
- Clinical safety, tolerability, and pharmacokinetics of murine monoclonal antibody to human tumor necrosis factor-alpha.
- Quantitation of unintegrated HIV-1 DNA in asymptomatic patients in the presence or absence of antiretroviral therapy.
- Rapid decrease in unintegrated human immunodeficiency virus DNA after the initiation of nucleoside therapy.
- Antiretroviral therapy is associated with a decrease in unintegrated HIV-1 DNA in pediatric patients.
- Treatment of Legionella pneumophila lung abscess with clindamycin.
- Legionella pneumophila serotype 3. A newly recognized pathogen.
- Antimicrobial susceptibility of Legionella pneumophila Serogroups I--IV.
- Failure of probenecid to alter the pharmacokinetics of ceforanide.
- The effect of inoculum, culture medium and antimicrobial combinations on the in-vitro susceptibilities of Legionella pneumophila.
- Community-acquired methicillin-resistant Staphylococcus aureus infections: a new source for nosocomial outbreaks.
Schools
University of Mi Med Sch
Henry Ford Hospital
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
Awards
- Super Doctor
Education
-
Henry Ford Hospital - Wayne State University -
University of Michigan Medical School
Hospital
-
St. John Hospital and Medical Center
Drug Facts
| NPI NUMBER | 1891788865 | |
| NPPES Provider LastName | SARAVOLATZ | |
| NPPES Provider FirstName | LOUIS | |
| NPPES Provider ZIPCode | 482362893 | |
| NPPES Provider State | MI | |
| Specialty Description | Infectious Disease | |
| Total Claim Count | 138.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1891788865 |
| Last Name Of The Provider | SARAVOLATZ |
| First Name Of The Provider | LOUIS |
| View All |
Similar Doctors
|
|
Dr. Mamta Sharma, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vijayalkshmi Nagappan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mohamad G. Fakih, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Danielle A. Osterholzer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rupal M. Mody, MD |
|
|
Dr. Anilrudh A. Venugopal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Preethi Sural, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Riad E. Khatib, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gordana Simeunovic, MD
This Doctor is OpenDoctor Recommended.
|